Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KIRTI SHETTY

Allopathic & Osteopathic Physicians Internal Medicine Transplant Hepatology

NPI
1669472429
CMS profile
74977
Location
BALTIMORE, MD

General Payments · PY2018–2024

$907.60

  • Reported across 27 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$454.39

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $454.39 14

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $100.00 1
PY2020 $34.78 2
PY2021 $141.90 3
PY2022 $68.59 3
PY2023 $107.94 4
PY2024 $454.39 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Gilead Sciences, Inc. $85.97 11/16/2024 Food and Beverage Undisputed 01/23/2026 1133828003 CMS
Intercept Pharmaceuticals, Inc. $21.12 04/15/2024 Food and Beverage Undisputed 01/23/2026 1113636896 CMS
Intercept Pharmaceuticals, Inc. $24.96 05/13/2024 Food and Beverage Undisputed 01/23/2026 1113636894 CMS
Intercept Pharmaceuticals, Inc. $26.15 06/17/2024 Food and Beverage Undisputed 01/23/2026 1113636892 CMS
Intercept Pharmaceuticals, Inc. $25.29 06/26/2024 Food and Beverage Undisputed 01/23/2026 1113636890 CMS
Ipsen Biopharmaceuticals, Inc $30.67 10/21/2024 Food and Beverage Undisputed 01/23/2026 1091989797 CMS
Mallinckrodt Hospital Products Inc. $35.74 02/13/2024 Food and Beverage Undisputed 01/23/2026 1145137001 CMS
Mallinckrodt Hospital Products Inc. $23.47 03/11/2024 Food and Beverage Undisputed 01/23/2026 1145137005 CMS
Mallinckrodt Hospital Products Inc. $31.27 07/02/2024 Food and Beverage Undisputed 01/23/2026 1145137009 CMS
Mallinckrodt Hospital Products Inc. $32.87 09/09/2024 Food and Beverage Undisputed 01/23/2026 1145137013 CMS
Mallinckrodt Hospital Products Inc. $31.96 10/28/2024 Food and Beverage Undisputed 01/23/2026 1145137018 CMS
Mallinckrodt Hospital Products Inc. $37.99 11/25/2024 Food and Beverage Undisputed 01/23/2026 1145137022 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $24.44 02/14/2024 Food and Beverage Undisputed 01/23/2026 1153515486 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $22.49 07/03/2024 Food and Beverage Undisputed 01/23/2026 1153553569 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.